Crediti Commerciali Cambiamento Data
Adma Biologics USD 135.86M 22.57M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
Novavax USD 106.45M 72.27M 2025-12
Omeros USD 8.08M 440K 2024-06
Takeda JPY 956.14B 79.79B 2026-06